🔗 Visit the ClinicalTrials.gov page for NCT00621686
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Pathway inhibition: emerging molecular targets for treating glioblastoma. | Neuro Oncol | 2011 | 1.38 |
| 2 | Experimental approaches for the treatment of malignant gliomas. | Pharmacol Ther | 2010 | 1.23 |
| 3 | Targeting Ras-RAF-ERK and its interactive pathways as a novel therapy for malignant gliomas. | Curr Cancer Drug Targets | 2010 | 1.07 |
| 4 | Molecularly targeted therapies for malignant glioma: rationale for combinatorial strategies. | Expert Rev Neurother | 2009 | 0.95 |
| 5 | NF-κB and STAT3 in glioblastoma: therapeutic targets coming of age. | Expert Rev Neurother | 2014 | 0.91 |